Planet Labs PBC heads into its June 4 earnings with a rare combination: short sellers pulling back hard into a rising stock, while options traders spike to their most defensive reading in months.
The week's most compelling tension is the divergence between shorts covering and options hedgers loading up. Short interest has dropped 13% over the past week alone to 11.1% of the free float — down from around 14.3% at the April peak. That's a meaningful unwind. It follows a 23% decline across the past month as the stock climbed 17% to $40.68. The covering has been swift and orderly, not forced. Borrow remains cheap at 0.56%, up about a third on the week but still well below any stress level. Borrow availability is in normal territory, and with the lending market relaxed, shorts have had every opportunity to exit cleanly.
Options positioning tells a different story. The put/call ratio jumped to 0.65 on May 12 — more than 2.3 standard deviations above its 20-day average of 0.47. That's the second-highest defensive reading of the past year, eclipsed only by the 0.70 print on April 30. While short sellers reduce exposure, options market participants are buying considerably more downside protection than usual. The two signals are pointing in opposite directions, and that tension sits right in front of a major catalyst.
Analyst coverage has shifted decisively upward following Planet Labs' strong February-quarter results. Most firms raised targets in the wake of the print, with Cantor Fitzgerald, Wedbush, and Needham all lifting their targets to $40 — the current stock price — while Goldman Sachs maintained a Neutral stance with a $20 target. The consensus price target now averages $35.22, which is roughly 13% below where the stock is currently trading. That gap is worth noting: the Street raised numbers into earnings strength, yet the stock has run further still, leaving the analyst community collectively offside on valuation. EPS surprise ranks in the 98th percentile universe-wide, and 90-day EPS momentum scores at the 96th percentile — the recent execution record has been exceptional. Yet with a negative earnings yield and an EV/EBITDA multiple north of 500x, the market is paying for future growth rather than current profitability.
The insider picture adds a layer of caution. CEO Will Marshall sold 200,000 shares on April 6 at $35.07 for over $7 million, while CFO Ashley Johnson sold a combined 200,000 shares across two transactions in early April totalling approximately $7 million. Co-founder Robbie Schingler also trimmed 73,683 shares. All three of the company's most senior figures reduced exposure within days of each other, shortly after the post-earnings surge. Net of awards, insiders sold a cumulative $34.9 million over the 90 days to mid-April. Coordination of that kind at the top of the house, into a sharp rally, is the kind of signal that warrants attention even when the operating narrative remains constructive.
The company meanwhile continues to win business. A new contract announced this week with the Czech government for AI-powered agricultural monitoring via its Sinergise subsidiary adds to the growing European commercial and sovereign pipeline that underpinned the recent earnings beat. Closest peer BlackSky Technology tracked PL closely, rising 12% on the week. Spire Global gained 7%, while Weldell surged 21% — the broader space-data cohort moved with PL rather than against it.
With next earnings confirmed for June 4, the setup is clear: a stock at all-time highs relative to analyst targets, a cluster of insider sales from the founding team, a short base that has covered aggressively, and options traders now loading up on protection. What to watch is whether new commercial contract announcements between now and June 4 sustain the bullish momentum — or whether the gap between the current price and analyst consensus draws fresh short interest back in.
See the live data behind this article on ORTEX.
Open PL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
